Navigate Titan Pharmaceuticals, Inc.
Home
About
Overview
Who We Are
IP Portfolio
Management Team
Board of Directors
Careers
Technology
Pipeline
Probuphine
Ropinirole Implant
T3 Implant
News
Overview
Press Releases
Events
Presentations
In the News
Publications
Posters
Media Resources
Investors
Investor Relations
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
Titan FCOI Policy
Financial Info
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact
Search
All SEC Filings
Home
Investors
SEC Filings
All SEC Filings
Investors
Navigate Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filter Filings:
View All
10-12G
10-12G/A
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB40
10QSB
15-12B
25
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
01/25/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
01/22/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
13
01/21/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
01/21/21
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
01/19/21
8-K
Current report filing
Related Documents
EX-4.1
EX-5.1
EX-10.1
EX-10.2
EX-99.1
34
01/19/21
424B5
Prospectus filed pursuant to Rule 424(b)(5)
34
01/08/21
8-K
Current report filing
2
01/07/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
13
12/31/20
8-K
Current report filing
2
12/31/20
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2
1
2
3
4
5
6
7
8
9
10
...86
Next >>